The editor's roundtable: lipid management beyond statins-reducing residual cardiovascular risk.
Friedewald
Vincent E
VE
Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, Texas, USA. vfriedew@nd.edu
Ballantyne
Christie M
CM
Davidson
Michael H
MH
Guyton
John R
JR
Roberts
William C
WC
D002318:Cardiovascular Diseases / Q000097:blood / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood*; D009017:Morbidity / Q000639:trends; D017063:Outcome Assessment, Health Care / Q000379:methods*; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids